Transdermal delivery of drugs for the treatment of bone diseases.
The current status of transdermal drug delivery for the treatment of bone diseases is described in this review. The structure, physiology and function of skin and their importance in determining delivery into and across skin are discussed. Special emphasis has been devoted to a description of the major pathways of transport across the skin and the quite continuing controversy over the importance of the transfollicular route. An overview of anatomic site-dependent drug absorption is also provided and is particularly relevant to determination of transdermal patch location. Brief descriptions of the criteria for selection of transdermal drug candidate, transdermal patch designs and currently marketed transdermal products are also included. Transdermal estradiol delivery systems are examined in more detail for their clinical and biological effects. Finally, the feasibility of delivering drugs such as bisphosphonates across skin is discussed.
Ramachandran
C
C
College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065, USA. rcmad@go.com
Fleisher
D
D
D000279:Administration, Cutaneous; D000818:Animals; D001692:Biological Transport; D001847:Bone Diseases / Q000188:drug therapy*; D004164:Diphosphonates / Q000008:administration & dosage; D016503:Drug Delivery Systems; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006801:Humans; D012867:Skin / Q000378:metabolism
D004164:Diphosphonates; D004958:Estradiol